SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey

Mixpanel is here to help gaming companies democratize their data

Here’s how gaming brands can reach wider audiences: “Never make assumptions!”

Israel’s gaming sector is 2% of its GDP - so why is the government ignoring it?

Buzz

Most popular

Daily

Weekly

1

From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey

2

TechAir flights from Israel to New York take off January 21

3

Defense tech is booming—but who will actually win?

4

Windward acquired for $270M by FTV Capital, doubling its IPO valuation

5

Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"

Biomed

8 stories about Biomed

תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich

This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman

Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer

Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday

נאסד"ק וול סטריט

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich

The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter

Biomed Company Protalix to Lay Off a Fifth of its Workforce

26.11.17|Dror Reich

The Israel-based NYSE American-listed company is currently undergoing a streamlining process

תרופות טבע גלולות תרופה

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer

The clinical stage company develops treatments mostly for osteoporosis and bone disorders

קולפלנט דיו ביולוגי

Collplant Takes a Step Towards 3D Organ Printing

17.10.17|Lilach Baumer

The Israel-based company develops collagen-based biological ink for 3D organ printing

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich

Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism

Previous Articles